Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Myocardial Infarction
5%
Adjusted Hazard Ratio
15%
Adult Patients
7%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
21%
Asian Patients
5%
Atrial Fibrillation
41%
Bipolar Disorder
8%
Cancer Inpatients
10%
Cancer Risk
24%
CHA2DS2-VASc Score
14%
Chemotherapy
6%
Chronic Obstructive Pulmonary Disease
8%
Colorectal Cancer
5%
Comorbidity
15%
Confidence Interval
43%
Depressive Disorder
5%
Early Mortality
5%
Graft-versus-host Disease (GvHD)
10%
Hazard Ratio
24%
Hematopoietic Stem Cell Transplantation
7%
High Risk
12%
Incidence Rate
8%
Independent Risk Factors
9%
Ischemic Stroke
14%
Leukemia Patients
6%
Multiple Myeloma
11%
Multiple Myeloma Patients
11%
Multivariate Analysis
7%
National Cohort Study
100%
National Health Insurance Research Database (NHIRD)
8%
New-onset Atrial Fibrillation
6%
Newly Diagnosed
13%
Newly Diagnosed multiple Myeloma
8%
Oral Anticoagulants
5%
Overall Survival
9%
Population-based Study
7%
Primary Central Nervous System Lymphoma (PCNSL)
6%
Prognostic Factors
5%
Radiotherapy
9%
Risk Factors
36%
Risk of Ischemic Stroke
17%
Risk of Malignancy
6%
Second Primary Malignancy
8%
Secondary Malignancy
6%
Standardized Incidence Ratio
23%
Stroke Risk
5%
Systemic Sclerosis
5%
Taiwan
45%
Taiwan National Health Insurance Research Database
11%
Tuberculosis
13%
Medicine and Dentistry
Allogeneic Hematopoietic Stem Cell Transplantation
9%
Apoplexy
13%
Atrial Fibrillation
28%
Brain Ischemia
11%
Breast Cancer
9%
Cancer
14%
Cancer Risk
8%
Case-Control Study
5%
CHA2DS2-VASc Score
11%
Chronic Obstructive Pulmonary Disease
5%
Cohort Analysis
32%
Colorectal Carcinoma
6%
Comorbidity
10%
Hazard Ratio
27%
Hematopoietic Stem Cell Transplantation
11%
Malignant Neoplasm
27%
Multiple Myeloma
12%
Multivariate Analysis
5%
Neoplasm
5%
Odds Ratio
5%
Overall Survival
8%
Population
5%
Primary Tumor
6%
Prognostic Factor
6%
Proportional Hazards Model
9%
Radiation Therapy
10%
Risk Stratification
6%
Second Cancer
9%
Standardized Incidence Ratio
21%
Systemic Lupus Erythematosus
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
5%
Acute Kidney Failure
5%
Anticoagulant Agent
5%
Atrial Fibrillation
31%
Bipolar Disorder
6%
Brain Ischemia
12%
Cerebrovascular Accident
11%
Chemotherapy
5%
Chronic Obstructive Lung Disease
8%
Cohort Study
35%
Comorbidity
12%
Congestive Heart Failure
5%
Diseases
6%
Graft Versus Host Reaction
5%
Infection
5%
Leukemia
5%
Malignant Neoplasm
20%
Multiple Myeloma
14%
Overall Survival
7%
Primary Central Nervous System Lymphoma
5%
Second Cancer
8%
Standardized Incidence Ratio
17%
Systemic Lupus Erythematosus
5%
Tuberculosis
5%